Elevance Health › Financials
Elevance Health financials
ELVTen years from Elevance Health’s own SEC filings. Fiscal years end in December.
Income statement
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.86B | $90.04B | $92.11B | $104.21B | $121.87B | $138.64B | $156.59B | $171.34B | $177.01B | $199.12B | $201.11B | — |
| Net income | $2.47B | $3.84B | $3.75B | $4.81B | $4.57B | $6.16B | $5.89B | $5.99B | $5.98B | $5.66B | $4.96B | — |
| Earnings per share, diluted | $9.21 | $14.35 | $14.19 | $18.47 | $17.98 | $24.95 | $24.28 | $25.22 | $25.68 | $25.21 | — | — |
Balance sheet
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $4.08B | $3.61B | $3.93B | $4.94B | $5.74B | $4.88B | $7.39B | $6.53B | $8.29B | $9.49B | — | $10.23B |
| Total assets | $65.08B | $70.54B | $71.57B | $77.45B | $86.61B | $97.46B | $102.77B | $108.93B | $116.89B | $121.49B | — | $126.44B |
| Debt | $15.29B | $18.66B | $18.07B | $19.39B | $20.04B | $22.76B | $23.85B | $24.89B | $30.87B | $31.90B | — | $31.04B |
| Total liabilities | $39.98B | $44.04B | $43.03B | $45.73B | $53.42B | $61.33B | $66.38B | $69.52B | $75.46B | $77.47B | — | $81.42B |
| Shareholders' equity | $25.10B | $26.50B | $28.54B | $31.73B | $33.20B | $36.06B | $36.31B | $39.31B | $41.31B | $43.88B | — | $44.88B |
Cash flow
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.27B | $4.18B | $3.83B | $6.06B | $10.69B | $8.36B | $8.40B | $8.06B | $5.81B | $4.29B | $7.46B | — |
| Capital spending | $584.0M | $791.0M | $1.21B | $1.08B | $1.02B | $1.09B | $1.15B | $1.30B | $1.26B | $1.12B | $1.18B | — |
| Buybacks | $0 | $2.00B | $1.69B | $1.70B | $2.70B | $1.90B | $2.32B | $2.68B | $2.90B | $2.60B | $2.71B | — |
| Dividends | $684.0M | $705.0M | $776.0M | $818.0M | $954.0M | $1.10B | $1.23B | $1.40B | $1.51B | $1.53B | $1.51B | — |
| Returned to shareholders | $684.0M | $2.70B | $2.46B | $2.52B | $3.65B | $3.00B | $3.54B | $4.07B | $4.41B | $4.13B | $4.21B | — |
| Stock-based pay | $165.0M | $170.0M | $226.0M | $294.0M | $283.0M | $255.0M | $264.0M | $289.0M | $191.0M | $276.0M | $244.0M | — |
Where these numbers come from
Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Gross profit, operating income and free cash flow are left out for banks, insurers and brokers, where they do not mean the same thing. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count
Elevance Health financials, answered
What is Elevance Health's market cap?
$92.88B at $428.26 a share, with 216,869,290 shares outstanding as of Jul 10, 2026, from the cover of its latest SEC filing.
How much does Elevance Health earn?
Revenue of $201.11B and net income of $4.96B in the last 12 months to Jun 2026.
How much debt does Elevance Health have?
Elevance Health reported $31.04B of debt and $10.23B of cash and equivalents on its balance sheet in Jun 2026.
How much cash does Elevance Health return to shareholders?
$4.13B in buybacks and dividends in fiscal 2025, from the cash flow statement.